Clinical trial
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative…
NCT00169988 · Northwell Health, Other · Completed
Key facts
| NCT number | NCT00169988 |
|---|---|
| Title | Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms |
| Official title | Sertraline Alone vs. in Combination With Risperidone in the Treatment of Attenuated Positive and Negative Symptoms |
| Lead sponsor | Northwell Health, Other |
| Collaborators | Stanley Medical Research Institute Janssen Pharmaceutica N.V., Belgium Industry Pfizer |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prodromal Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | risperidone, sertraline-primary |
| Enrollment | 8 |
| Start date | Mar 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: